Hedera Dx News

May 27, 2025
Hedera Dx Secures €15 Million Series A to bring modern cancer care to patients across the globe

May 27, 2025
Hedera Dx Secures €15 Million Series A to bring modern cancer care to patients across the globe

October 28, 2024
Hedera Dx Announces Publication of International, Multicenter, Pan-Cancer Liquid Biopsy Test Panel Analytical Validation in medRxiv

October 28, 2024
Hedera Dx Announces Publication of International, Multicenter, Pan-Cancer Liquid Biopsy Test Panel Analytical Validation in medRxiv

September 18, 2024
Hedera Dx Expects Increased Liquid Biopsy Adoption With Real-World Data Cancer Registries

September 18, 2024
Hedera Dx Expects Increased Liquid Biopsy Adoption With Real-World Data Cancer Registries

September 16, 2024
Positive clinical progress in the biotech scene

September 16, 2024
Positive clinical progress in the biotech scene
.png)
September 13, 2024
Hedera Dx Launches AI-Enabled RWD Capabilities with First Patients Recruited in EMPATHY NSCLC: a Prospective, International, Decentralized, Multicenter, Real-World Utility Study for Liquid Biopsy
.png)
September 13, 2024
Hedera Dx Launches AI-Enabled RWD Capabilities with First Patients Recruited in EMPATHY NSCLC: a Prospective, International, Decentralized, Multicenter, Real-World Utility Study for Liquid Biopsy